Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TLSA |
---|---|---|
09:32 ET | 17779 | 1.0601 |
09:34 ET | 776 | 1.07 |
09:36 ET | 1812 | 1.0676 |
09:38 ET | 100 | 1.0812 |
09:43 ET | 14263 | 1.075 |
09:45 ET | 805 | 1.075 |
09:48 ET | 600 | 1.06 |
09:52 ET | 1801 | 1.0865 |
09:56 ET | 8304 | 1.0645 |
09:57 ET | 1400 | 1.0624 |
09:59 ET | 1000 | 1.075 |
10:01 ET | 339 | 1.07 |
10:03 ET | 100 | 1.07 |
10:06 ET | 100 | 1.06 |
10:08 ET | 1992 | 1.075 |
10:10 ET | 8604 | 1.05 |
10:15 ET | 1000 | 1.0481 |
10:17 ET | 700 | 1.03 |
10:19 ET | 3250 | 1.0222 |
10:21 ET | 120 | 1.0391 |
10:28 ET | 2999 | 1.02 |
10:30 ET | 12346 | 1.02 |
10:33 ET | 3300 | 1.035 |
10:37 ET | 2000 | 1.0354 |
10:44 ET | 2300 | 1.03 |
10:50 ET | 100 | 1.03 |
10:51 ET | 25065 | 1.02 |
10:53 ET | 32000 | 1.03 |
10:57 ET | 300 | 1.03 |
11:00 ET | 5000 | 1.04 |
11:02 ET | 3000 | 1.02 |
11:04 ET | 1074 | 1.0219 |
11:06 ET | 494 | 1.039 |
11:08 ET | 4000 | 1.0212 |
11:11 ET | 100 | 1.03 |
11:18 ET | 500 | 1.0264 |
11:20 ET | 3491 | 1.02 |
11:22 ET | 1400 | 1.0217 |
11:24 ET | 19636 | 1.04 |
11:27 ET | 200 | 1.035 |
11:31 ET | 200 | 1.05 |
11:36 ET | 1000 | 1.035 |
11:40 ET | 500 | 1.025 |
11:42 ET | 3222 | 1.0299 |
11:44 ET | 2982 | 1.0399 |
11:45 ET | 1000 | 1.0399 |
11:47 ET | 2100 | 1.035 |
11:49 ET | 128 | 1.04 |
11:51 ET | 200 | 1.04 |
11:56 ET | 1000 | 1.0481 |
12:02 ET | 200 | 1.0473 |
12:07 ET | 100 | 1.05 |
12:21 ET | 7000 | 1.03 |
12:25 ET | 2100 | 1.05 |
12:27 ET | 400 | 1.0365 |
12:39 ET | 800 | 1.035 |
12:43 ET | 900 | 1.035 |
12:48 ET | 100 | 1.04 |
12:50 ET | 400 | 1.04 |
01:06 ET | 100 | 1.03 |
01:14 ET | 600 | 1.035 |
01:17 ET | 500 | 1.035 |
01:21 ET | 800 | 1.03 |
01:28 ET | 200 | 1.03 |
01:30 ET | 3478 | 1.05 |
01:48 ET | 100 | 1.05 |
02:04 ET | 368 | 1.0374 |
02:08 ET | 100 | 1.05 |
02:11 ET | 188 | 1.0473 |
02:20 ET | 100 | 1.03 |
02:22 ET | 999 | 1.0371 |
02:26 ET | 100 | 1.05 |
02:31 ET | 400 | 1.04 |
02:44 ET | 100 | 1.05 |
02:56 ET | 100 | 1.04 |
02:58 ET | 552 | 1.0409 |
03:00 ET | 1500 | 1.0406 |
03:02 ET | 100 | 1.05 |
03:12 ET | 567 | 1.045 |
03:18 ET | 1352 | 1.05 |
03:23 ET | 200 | 1.045 |
03:27 ET | 200 | 1.045 |
03:32 ET | 100 | 1.05 |
03:41 ET | 100 | 1.05 |
03:43 ET | 710 | 1.04 |
03:45 ET | 2509 | 1.04 |
03:48 ET | 100 | 1.04 |
03:50 ET | 100 | 1.03 |
03:52 ET | 100 | 1.05 |
03:54 ET | 600 | 1.04 |
03:56 ET | 4900 | 1.03 |
03:57 ET | 2141 | 1.02 |
03:59 ET | 10984 | 1.02 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Tiziana Life Sciences Ltd | 114.1M | -5.9x | --- |
Verastem Inc | 113.9M | -0.9x | --- |
ALX Oncology Holdings Inc | 114.3M | -0.6x | --- |
Annovis Bio Inc | 112.8M | -1.9x | --- |
Regulus Therapeutics Inc | 111.9M | -1.4x | --- |
Fibrobiologics Inc | 111.1M | -3.5x | --- |
Tiziana Life Sciences Ltd. is a United Kingdom-based clinical-stage biotechnology company. The Company develops transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for secondary progressive multiple sclerosis, Crohn's Disease and KRAS+ NSCLC. Its pipeline candidates include Foralumab (TZLS-401), Anti IL-6R mAb (TZLS-501) and Milciclib (TZLS-201). Foralumab (TZLS-401) is a fully human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn’s and neurodegenerative diseases. Its Anti IL-6R mAb (TZLS-501), a fully human mAb binds to both membrane-bound and soluble forms of IL-6R, an inflammatory cytokine driving chronic inflammation associated with autoimmune disease and cancer, reducing circulating levels of the IL-6 cytokine. Milciclib is a potent, small molecule inhibitor of multiple cyclin-dependent kinases (CDKs), tropomycinreceptor kinases and Src family kinases controlling cell growth and malignant progression of cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $114.1M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 103.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.44 |
EPS | $-0.17 |
Book Value | $0.05 |
P/E Ratio | -5.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.